FARM TO PHARM

Serial Number 77747865
602

Registration Progress

Application Filed
May 29, 2009
Under Examination
Approved for Publication
Published for Opposition
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: FARM TO PHARM
Previous Owner: PurGenesis Technologies, Inc.
Classes: 003, 004, 005, 010, 016, 040, 042, 044

Trademark Image

FARM TO PHARM

Basic Information

Serial Number
77747865
Filing Date
May 29, 2009
Abandonment Date
February 4, 2014
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Mar 13, 2014
Classes
003 004 005 010
+4 more

Rights Holder

PurGenesis Technologies, Inc.

11
Address
262, 12e Rue
Montmagny, Quebec G5V3X9
CA

Ownership History

PurGenesis Technologies, Inc.

Original Applicant
11
Montmagny, Quebec CA

Legal Representation

Attorney
George A. Pelletier, Jr.

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

50 events
Date Code Type Description Documents
Mar 13, 2014 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Mar 13, 2014 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Aug 2, 2013 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Aug 2, 2013 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Aug 2, 2013 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Jul 30, 2013 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Jan 28, 2013 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Jan 28, 2013 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Jan 28, 2013 CNSL R SUSPENSION LETTER WRITTEN Loading...
Jan 22, 2013 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 22, 2013 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 22, 2013 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jan 9, 2013 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 9, 2013 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 9, 2013 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Jul 10, 2012 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Jul 10, 2012 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Jul 10, 2012 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Jun 29, 2012 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Jun 1, 2012 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 27, 2011 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Dec 27, 2011 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Dec 27, 2011 CNSL R SUSPENSION LETTER WRITTEN Loading...
Dec 7, 2011 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 7, 2011 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 21, 2011 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
May 20, 2011 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
May 20, 2011 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
May 20, 2011 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Apr 28, 2011 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Apr 28, 2011 ALIE A ASSIGNED TO LIE Loading...
Oct 27, 2010 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Oct 27, 2010 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Oct 27, 2010 CNSL R SUSPENSION LETTER WRITTEN Loading...
Oct 7, 2010 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 6, 2010 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 6, 2010 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 6, 2010 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 6, 2010 GNRT O NON-FINAL ACTION E-MAILED Loading...
Apr 6, 2010 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 13, 2010 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 13, 2010 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 13, 2010 ALIE A ASSIGNED TO LIE Loading...
Mar 1, 2010 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 4, 2009 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 4, 2009 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 4, 2009 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 28, 2009 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 3, 2009 MPMK O NOTICE OF PSEUDO MARK MAILED Loading...
Jun 2, 2009 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 003
hair care products, namely, shampoo, hair shampoo concentrate, conditions, conditioner shampoo, neutralizer shampoo, re-hydrating shampoo, conditioner and hair dressing, hair color, hair dye, hair highlights, hair frost, hair bleach, peroxide, hair rinse and setting preparation, instant hair conditioner, hair spray, hair finisher, hair relaxer, hair straightening preparation, anti-frizz preparation, hair permanent waving and curling preparation, preparation for increasing hair body, rinse for controlling, preventing and treating dandruff, sun lotion and sun screen preparation for the hair, preparation for after sun care of the hair, hair styling gel, hair mask, hair wax, mustache wax, hair setting lotion, hair moisturizing lotion, hair oil, shaving soap, shaving cream, shaving gel, shaving balm, electric shaving lotion, after shave lotion, hair affixing tape and strips, spirit gum, hair piece remover, hair piece cleaner, permanent wave kits containing relaxer, neutralizing shampoo and hair setting lotion and gloves for use in applying the contents of the kit, and kits for the hair consisting of relaxer, conditioners, protective gel for the scalp, hair dressing and gloves for use in applying the contents of the kit; cosmetic products, namely, nail polish, nail varnish, nail polish remover, nail conditioner, emery paper; pumice stone; cosmetic dyes,anti-aging creams and serums, suntan lotion, suntan oil, sun screen, sun block, after sun lotion, colorants for the face, skin tanning lotion and cream, skin tanning spray, depilatories; lipstick, lip gloss, lip balm, lip sun screen, eye liner, mascara, eye shadow, eye brow pencil, face powder, foundation liquid and cream, liquid make up, powder make up, liquid blush, powder blush, make up removing preparations, make up compacts with puff with and without make up contents, blusher compacts with brush and with and without blusher contents, lipstick and lip gloss compacts with applicator and with and without lipstick or lip gloss, cotton swabs, cotton balls, exfoliant pads and cloths, tooth gel, tooth paste, tooth polish, tooth powder, tooth whitener and bleach; and mouth wash; body care products, namely, essential oil, massage oil, cleansing lotion and cleansing oil, astringents, night cream, anti-wrinkle cream and lotion, barrier cream, body cream and mud, mask preparation for treating the skin, bath salts, bubble bath, bath foam, bath oil, bath and shower gel, liquid and bar soap for personal use, body scrub and exfoliant; shaving soap, antiperspirant, talcum powder, body powder, perfume, eau de cologne, deodorant for personal use, perfuming sachets
First Use Anywhere: 0
First Use in Commerce: 0
Class 004
biofuels, namely, gaseous, solid and liquid fuel derived from plant and other biomass material
First Use Anywhere: 0
First Use in Commerce: 0
Class 005
pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention, treatment and alleviation of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of central nervous system disorders, diseases, conditions and ailments, namely, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, insomnia, mood disorders, bipolar disorder, seizure disorders and smoking habits or addictions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of neurological disorders, diseases, conditions and ailments, namely, brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, and cerebral palsy; pharmaceutical preparations and substances for the prevention, treatment and alleviation of psychiatric disorders, diseases, conditions and ailments, namely, mood disorders, anxiety disorders, panic disorders, bipolar disorders, cognitive disorders, schizophrenia, and depression; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of immunological disorders, diseases, conditions and ailments, namely, autoimmune diseases, immunological deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS), immunological dysfunctions, hypersensitivity, allergies, and tumors of the immunological organs; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculoskeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of irritable bowel disorder, Crohn's disease and ulcerative colitis; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis, psoriasis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; and nutritional supplements, namely, vitamins, minerals, glucosamine and chondroitin; extended release formulations, compositions and agents for use in the manufacture of human and veterinary medicinal products for the treatment of infertility, diabetes, and/or insulin imbalances; oral extended release pharmaceuticals for the treatment of angina and hypertension; rapidly dissolving matrix preparations for the delivery of medicinal active ingredients for the treatment of humans and for veterinary use botanical preparations and substances for the prevention, treatment and alleviation of stress; botanical preparations and substances for the prevention, treatment and alleviation of diabetes; botanical preparations and substances for the prevention, treatment and alleviation of hypertension; botanical preparations and substances for the prevention, treatment and alleviation of angina; botanical preparations and substances for the cessation of smoking; botanical preparations and substances for the prevention, treatment and alleviation of sexually transmitted diseases; botanical preparations and substances for the prevention, treatment and alleviation of herpes; botanical preparations and substances for the prevention, treatment and alleviation central nervous system disorders, diseases, conditions and ailments, namely, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, insomnia, mood disorders, bipolar disorder, seizure disorders and smoking habits or addictions; botanical preparations and substances for the prevention, treatment and alleviation of neurological disorders, diseases, conditions and ailments, namely, brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, and cerebral palsy; botanical preparations and substances for the prevention, treatment and alleviation of psychiatric disorders, diseases, conditions and ailments, namely, mood disorders, anxiety disorders, panic disorders, bipolar disorders, cognitive disorders, schizophrenia, and depression; botanical preparations and substances for the prevention, treatment and alleviation of depression; botanical based anti-depressants; botanical preparations and substances for the prevention, treatment and alleviation of sleep disorders; botanical preparations and substances for the prevention, treatment and alleviation of anxiety; botanical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardiovascular system; botanical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; botanical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; botanical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; botanical preparations and substances, namely, fibrinolytic or thrombolytic agents; botanical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; botanical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; botanical preparations and substances for the prevention, treatment and alleviation of immunological disorders, diseases, conditions and ailments, namely, autoimmune diseases, immunological deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS), immunological dysfunctions, hypersensitivity, allergies, tumors of the immunological organs; botanical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculoskeletal system, namely, bone diseases and bone degenerative conditions; botanical preparations and substances for the preventions treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; botanical preparations and substances for the prevention, treatment and alleviation of irritable bowel disorder, Crohn's disease and ulcerative colitis; botanical preparations and substances for the prevention, treatment and alleviation of migraines; botanical preparations and substances, namely, botanical skin care preparations for use in dermatology, namely, dermatitis, psoriasis and skin pigmentation diseases; botanical preparations and substances for use in oncology; botanical preparations and substances for use in ophthalmology; and botanical based nutritional supplements, namely, vitamins, minerals, glucosamine and chondroitin; botanical preparations and substance delivery platforms for controlling the solubility, compressibility and/or flowability of botanical preparations and substances; extended release formulations, compositions, and agents for use in the manufacture of human and veterinary botanical products for the treatment of circulatory, respiratory, endocrine, neurologic, cardio vascular, alimentary, oncologic, auto-immune or immune-related, pulmonary, musculoskeletal, lymphatic gastrointestinal, bone, sensory, viral, urinary, renal, infectious, metabolic or central nervous system diseases, illnesses, disorders or conditions; extended release formulations, compositions and agents for use in the manufacture of human and veterinary botanical products for the treatment of infertility, diabetes, and/or insulin imbalances; oral extended release botanical preparations formulations, compositions and agents for use in the manufacture of human and veterinary botanical products for the treatment of infertility, diabetes, and/or insulin imbalances; oral extended release botanical preparations and substances for the treatment of angina and hypertension; rapidly dissolving matrix preparations for the delivery of botanical active ingredients for the treatment of humans and for veterinary use biosensors for the identification and determination of concentration of substances and other parameters of biological interest; cosmeceutical products, namely, general and advanced hair care, cosmetic, tooth and mouth care, body care, anti-aging and anti-oxidant product lines that have medicinal or drug-like benefits; medical devices, namely, medical instruments for human and veterinary use
First Use Anywhere: 0
First Use in Commerce: 0
Class 010
drug delivery platforms for controlling the solubility, compressibility and/or flowability of drugs; extended release formulations, compositions and agents for use in the manufacture of human and veterinary medicinal products for the treatment of circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, oncologic, auto-immune or immune-related, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious, metabolic or central nervous system diseases, illnesses, disorders or conditions; implantable and extra-corporeal medical devices for human and veterinary non-invasive or surgical repair, fixation, support, immobilization or stabilization of trauma, fractures, disease, disorders, conditions and ailments; prostheses for human and veterinary use
First Use Anywhere: 0
First Use in Commerce: 0
Class 016
paper towels, facial tissues; printed matter, namely, product monographs, training materials, conference programs, newsletters, brochures, posters, banners, and reports, all relating to the fields of pharmaceuticals, botanical products, biosensors, advanced biofuels, cosmeceutical products, body care, hair care, cosmetics, tooth and mouth care products and medical services; registration, manufacture, and sales of general product lines and advanced pharmaceutical products in the field of pharmaceuticals to the order and specification of others; research and development in the field of pharmaceuticals; formulation development, clinical evaluation and testing, regulatory registration and joint venture/licensing of pharmaceutical compounds; registration, manufacture, and sales of general product lines and advanced botanical products in the field of botanical products to the order and specification of others; research and development in the field of botanical products; formulation development
First Use Anywhere: 0
First Use in Commerce: 0
Class 040
registration, manufacture, and sales of general product lines and advanced biosensors in the field of biosensors to the order and specification of others
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
research and development in the field of biosensors; research and development in the field of biofuels
First Use Anywhere: 0
First Use in Commerce: 0
Class 044
clinical evaluation and testing, regulatory registration and joint venture/licensing of botanical products; formulation development, clinical evaluation and testing, regulatory registration and joint venture/licensing of biosensors; registration, manufacture, and sales of general product lines and advanced biofuels in the field of biofuels to the order and specification of others; formulation development, clinical evaluation and testing, regulatory registration and joint venture/licensing of biofuels; registration, manufacture and sales of general product lines and advanced cosmeceutical products in the field of cosmeceutical products to the order and specification of others; research and development in the field of cosmeceutical products; formulation development, clinical evaluation and testing, regulatory registration and joint venture/licensing of cosmeceutical products; registration, manufacture and sales of general product lines and advanced hair care, cosmetic, tooth and mouth care and body care products in the field of hair care, cosmetic, tooth and mouth care and body care products to the order and specification of others; research and development in the field of hair care, cosmetic, tooth and mouth care and body care products; registration, manufacture, and sales of general product lines and advanced medical devices in the field of medical devices to the order and specification of others; research and development in the field of medical devices; formulation development, clinical evaluation and testing, regulatory registration and joint venture/licensing of medical devices
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
FARM TO PHARMACEUTICAL

Classification

International Classes
003 004 005 010 016 040 042 044